Motor neuron disease recovery associated with IV ceftriaxone and anti-Babesia therapy

Acta Neurologica Scandinavica

Volumn 115, Issue 2, 2007, Pages 129-131

  Harvey, W T ^a   Martz, D ^a  

^a Rocky Mountain Chronic Disease Specialists   (United States)

Author keywords

Amyotrophic lateral sclerosis; Atovaquone; Babesia; Borrelia; Ceftriaxone; Motor neuron disease

Indexed keywords

ANTIBIOTIC AGENT; ANTIPARASITIC AGENT; ATOVAQUONE; AZITHROMYCIN; CEFTRIAXONE; DOXYCYCLINE; MEFLOQUINE; URSODEOXYCHOLIC ACID;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANTIBIOTIC THERAPY; BILE SLUDGING; BORRELIA BURGDORFERI; CASE REPORT; CONVALESCENCE; DRUG EFFICACY; ERYTHROCYTE; GALLSTONE; HUMAN; MALE; MOTOR NEURON DISEASE; NEUROLOGIC EXAMINATION; PARASITOSIS; REVIEW; SYMPTOM; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ATOVAQUONE; CEFTRIAXONE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; RECOVERY OF FUNCTION;

EID: 33845884031     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00727.x     Document Type: Review

References (24)

1. ZANNI GR, WICK JY. The steady, inevitable decline of amyotrophic lateral sclerosis patients. Consult Pharm 2005;20:803-4. 806-8, 810-12.
2. ARGYRIOU AA, POLYCHRONOPOULOS P, P APAPETROPOULOS S et al. Clinical and epidemiological features of motor neuron disease in south-western Greece. Acta Neurol Scand 2005;111:108- 13.
3. DEL AGUILA MA, LONGSTRETH JR WT, MCGUIRE V, KOEPSELL TD, VAN BELLE G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003;60:813-9.
4. POUGET J. Clinical neurophysiology for estimation of progression and prognosis in ALS. Rev Med Liege 2004;59(Suppl 1):32-7.
5. SCHMIDT EP, DRACHMAN DB, WIENER CM, CLAWSON L, KIMBALL R, LECHTZIN N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve 2006;33:127-32.
6. JI HF, SHEN L, ZHANG HY. Beta-lactam antibiotics are multipotent agents to combat neurological diseases. Biochem Biophys Res Commun 2005;333:661-3.
7. ROTHSTEIN JD, PATEL S, REGAN MR et al. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005;433:73-7.
8. COURATIER P, VALLAT JM, MERLE L, PREUX PM, HUGON J. Report of six sporadic cases of ALS patients receiving ceftriaxone. Therapie 1994;49:146.
9. GORDON PH, MOORE DH, GELINAS DF et al. Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology 2004;62:1845-7.
10. PONTIERI FE, RICCI A, PELLICANO C, BENINCASA D, BUTTARELLI FR. Minocycline in amyotrophic lateral sclerosis: a pilot study. Neurol Sci 2005;26:285-7.
11. HALPERIN JJ, KAPLAN GP, BRAZINSKY S et al. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 1990;47:586-94.
12. HANSEL Y, ACKERL M, STANEK G. ALS-like sequelae in chronic neuroborreliosis. Wien Med Wochenschr 1995;145:186-8.
13. WEDER B, WIEDERSHEIM P, MATTER L, STECK A, OTTO F. Chronic progressive neurological involvement in Borrelia burgdorferi infection. J Neurol 1987;234:40-3.
14. ASBRINK E, HOVMARK A. Comments on the course and classification of Lyme borreliosis. Scand J Infect Dis Suppl 1991;77:41-3.
15. HALPERIN J, LUFT BJ, VOLKMAN DJ, DATTWYLER RJ. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain 1990;113:1207-21.
16. PETROVIC M, VOGELAERS D, VAN RENTERGHEM L, CARTON D, DE REUCK J, AFSCHRIFT M. Lyme borreliosis - a review of the late stages and treatment of four cases. Acta Clin Belg 1998;53:178-83.
17. NORRIS FH. Ceftriaxone in amyotrophic lateral sclerosis. Arch Neurol 1994;51:447.
18. SMITH LG. Failure of ceftriaxone for amyotrophic lateral sclerosis. Lancet 1992;340:379.
19. SMITH LG. Improvement of patient with amyotrophic lateral sclerosis given ceftriaxone. Lancet 1992;339:1417.
20. BEGHI E, BENDOTTI C, MENNINI T. Merits of a new drug trial for ALS? Science 2005;308:632-3. (author reply 632-33).
21. BROWN JR RH. Amyotrophic lateral sclerosis - a new role for old drugs. N Engl J Med 2005;352:1376-8.
22. MILLER TM, CLEVELAND DW. Medicine. Treating neurodegenerative diseases with antibiotics. Science 2005;307:361-2.
23. TIKKA T, USENIUS T, TENHUNEN M, KEINANEN R, KOISTINAHO J. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation. J Neurochem 2001;78:1409-14.
24. KRAUSE PJ, TELFORD III SR, SPIELMAN A et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA 1996;275:1657-60.